Q2 FY2026 EarningsQ2 FY26 missed consensus estimates significantly as revenue of $1.23M fell 71.11% below the $4.24M expected. Gross margin of 15.76% was a severe miss against the 74.00% target, primarily due to one-time inventory liquidations. GAAP net loss was $12.80M, more than double the consensus expectation of a $5.96M loss, while GAAP EPS of -$15.70 appeared to beat the -$52.15 target primarily due to significant share dilution throughout the quarter.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Jaguar Health(JAGX) the Revenue is 1.225 M (-58.88%);the EBIT is -7.597 M (+5.12%);the EPS is -15.7 (+95.63%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B58.88%
----
----
EBIT
-0.01B5.12%
----
----
EPS
-15.697395.63%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf